J J Oliver

Summary

Affiliation: University of Edinburgh
Country: UK

Publications

  1. ncbi Venlafaxine poisoning complicated by a late rise in creatine kinase: two case reports
    J J Oliver
    Scottish Poisons Information Bureau, NPIS Edinburgh, Royal Infirmary, UK
    Hum Exp Toxicol 21:463-6. 2002
  2. ncbi Noninvasive assessment of arterial stiffness and risk of atherosclerotic events
    James J Oliver
    Clinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, Scotland, UK
    Arterioscler Thromb Vasc Biol 23:554-66. 2003
  3. ncbi Stimulated tissue plasminogen activator release as a marker of endothelial function in humans
    James J Oliver
    Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
    Arterioscler Thromb Vasc Biol 25:2470-9. 2005
  4. doi Patterns and predictors of re-admission to hospital with self-poisoning in Scotland
    R A Payne
    Queen s Medical Research Institute, Clinical Pharmacology Unit, University of Edinburgh, 47 Little France Crescent, Edinburgh EH164TJ, UK
    Public Health 123:134-7. 2009
  5. ncbi Poisons admissions in Edinburgh 1981-2001: agent trends and predictors of hospital readmissions
    S B Rafnsson
    Department of Public Health Sciences, University of Edinburgh Medical School, Teviot Place, EH8 9AG, Edinburgh, UK
    Hum Exp Toxicol 26:49-57. 2007
  6. ncbi No adverse hemodynamic interaction between sildenafil and red wine
    Stephen J Leslie
    Centre for Cardiovascular Science, The University of Edinburgh, Western General Hospital, United Kingdom
    Clin Pharmacol Ther 76:365-70. 2004
  7. ncbi Endothelial fibrinolytic function in hypertension: the expanding story
    James J Oliver
    J Hypertens 23:1471-2. 2005
  8. ncbi Effect of regular phosphodiesterase type 5 inhibition in hypertension
    James J Oliver
    University of Edinburgh, United Kingdom
    Hypertension 48:622-7. 2006
  9. ncbi Dose-response relationship of sublingual nitroglycerin with brachial artery dilatation and change in central and peripheral augmentation index
    James J Oliver
    Clin Pharmacol Ther 77:337-8. 2005
  10. ncbi Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension
    John Deanfield
    Vascular Physiology Unit, Institute of Child Health and Great Ormond Street Hospital NHS Trust, London, UK
    J Hypertens 23:7-17. 2005

Detail Information

Publications13

  1. ncbi Venlafaxine poisoning complicated by a late rise in creatine kinase: two case reports
    J J Oliver
    Scottish Poisons Information Bureau, NPIS Edinburgh, Royal Infirmary, UK
    Hum Exp Toxicol 21:463-6. 2002
    ..Although the clinical consequences were not serious, physicians should be alerted to the possibility of delayed rhabdomyolysis or serotonin syndrome in patients who have taken venlafaxine in overdose...
  2. ncbi Noninvasive assessment of arterial stiffness and risk of atherosclerotic events
    James J Oliver
    Clinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, Scotland, UK
    Arterioscler Thromb Vasc Biol 23:554-66. 2003
    ..Finally, the effects of current and future cardiovascular drugs on arterial stiffness are also discussed, as is the relationship between arterial elasticity and endothelial function...
  3. ncbi Stimulated tissue plasminogen activator release as a marker of endothelial function in humans
    James J Oliver
    Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
    Arterioscler Thromb Vasc Biol 25:2470-9. 2005
    ..The investigation of endothelial fibrinolytic function has the potential to provide major new insights into the pathophysiology of cardiovascular disease, and to shape future therapeutic interventions...
  4. doi Patterns and predictors of re-admission to hospital with self-poisoning in Scotland
    R A Payne
    Queen s Medical Research Institute, Clinical Pharmacology Unit, University of Edinburgh, 47 Little France Crescent, Edinburgh EH164TJ, UK
    Public Health 123:134-7. 2009
    ..To identify factors influencing hospital re-admission with self-poisoning...
  5. ncbi Poisons admissions in Edinburgh 1981-2001: agent trends and predictors of hospital readmissions
    S B Rafnsson
    Department of Public Health Sciences, University of Edinburgh Medical School, Teviot Place, EH8 9AG, Edinburgh, UK
    Hum Exp Toxicol 26:49-57. 2007
    ..Information on drug type used in self-poisoning may assist in identifying patients at risk for future events, and in reducing hospital readmissions...
  6. ncbi No adverse hemodynamic interaction between sildenafil and red wine
    Stephen J Leslie
    Centre for Cardiovascular Science, The University of Edinburgh, Western General Hospital, United Kingdom
    Clin Pharmacol Ther 76:365-70. 2004
    ..Alcohol is a commonly used recreational substance with complex vascular effects, which may, in part, be mediated by nitric oxide. Thus there is potential for an adverse hemodynamic interaction...
  7. ncbi Endothelial fibrinolytic function in hypertension: the expanding story
    James J Oliver
    J Hypertens 23:1471-2. 2005
  8. ncbi Effect of regular phosphodiesterase type 5 inhibition in hypertension
    James J Oliver
    University of Edinburgh, United Kingdom
    Hypertension 48:622-7. 2006
    ..In conclusion, regular sildenafil constitutes effective antihypertensive therapy. Further studies are warranted to evaluate the role of longer-acting phosphodiesterase type 5 inhibitors as antihypertensive agents in clinical practice...
  9. ncbi Dose-response relationship of sublingual nitroglycerin with brachial artery dilatation and change in central and peripheral augmentation index
    James J Oliver
    Clin Pharmacol Ther 77:337-8. 2005
  10. ncbi Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension
    John Deanfield
    Vascular Physiology Unit, Institute of Child Health and Great Ormond Street Hospital NHS Trust, London, UK
    J Hypertens 23:7-17. 2005
    ..Thus, the most relevant methodological issues in the research on endothelial function and dysfunction are summarized in this paper...
  11. ncbi Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension
    Hanspeter Brunner
    Division of Cardiology, University Hospital, Basel, Switzerland
    J Hypertens 23:233-46. 2005
    ..This paper will provide a concise overview of the mechanisms causing endothelial dysfunction in the different cardiovascular risk factors and disease conditions, and of the impact of the intervention measures and treatments...
  12. pmc Journals should select drug advertisements more carefully
    James J Oliver
    BMJ 326:1211. 2003
  13. pmc Contribution of the M3 muscarinic receptors to the vasodilator response to acetylcholine in the human forearm vascular bed
    Teresa M Attinà
    Clinical Pharmacology Unit, Centre for Cardiovascular Science, Queen s edical Research Institute, University of Edinburgh, Edinburgh, Scottland, UK
    Br J Clin Pharmacol 66:300-3. 2008
    ..Darifenacin is a recently developed antimuscarinic drug with greater M(3) selectivity, and our main objective was to investigate whether darifenacin affects dose-dependent vasodilatation to ACh in the forearm circulation...